Skip to main content
    A

    Adaptive Biotechnologies Corp (ADPT)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $27.87
    -1.17 (-4.03%)

    Market Cap: $4.70B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Adaptive Biotechnologies Corp (ADPT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Adaptive Biotechnologies are CareDx (CDNA), GRAIL, LLC (GRAL) and Sotera Health (SHC). By market cap, Adaptive Biotechnologies ranks 7th of the 13 companies on this page; Revvity (RVTY) is the largest at $17.24B. The median P/E of the 9 companies with a P/E is 31.8x.

    Peer Comparison

    ADPT's revenue growth of -10.7% is below the peer median of 13.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Adaptive Biotechnologies (ADPT)$4.70BN/A15.0x-23.7%N/A-10.7%0.00%
    CareDx Inc (CDNA)$4.09B48.2x6.4x25.9%N/A39.3%0.00%
    GRAIL, LLC (GRAL)$5.21BN/A29.6x-243.8%N/A3.7%0.00%
    Sotera Health Co (SHC)$4.74B17.1x3.8x14.1%9.0%4.4%0.00%
    Veracyte Inc (VCYT)$1.96B13.3x3.3x21.8%8.2%15.1%0.00%
    RadNet Inc (RDNT)$6.02B141.5x2.5x-0.9%2.7%22.1%0.00%
    NeoGenomics Inc (NEO)$2.07B228.9x2.6x-4.1%-2.5%11.4%0.00%
    Personalis Inc (PSNL)$1.70BN/A20.9x-147.7%N/A76.6%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Qiagen NV (QGEN)$10.30B20.5x4.9x18.2%8.2%2.9%0.70%
    Charles River Laboratories (CRL)$16.19B31.8x4.0x1.0%0.1%-2.2%0.00%
    Castle Biosciences Inc (CSTL)$1.04BN/A2.7x-6.1%-5.4%23.9%0.00%
    Revvity Inc. (RVTY)$17.24B26.8x5.6x8.6%3.4%4.3%0.19%
    Peer median$4.42B31.8x3.9x0.5%3.0%13.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Adaptive Biotechnologies, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Diagnostics & Research; the other one is in Biotechnology.

    CompanyAboutPeers
    CareDx Inc (CDNA)Diagnostics & Research
    CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally.
    CDNA competitors
    GRAIL, LLC (GRAL)Diagnostics & Research
    GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics...
    GRAL competitors
    Sotera Health Co (SHC)Diagnostics & Research
    Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical...
    SHC competitors
    Veracyte Inc (VCYT)Diagnostics & Research
    Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
    VCYT competitors
    RadNet Inc (RDNT)Diagnostics & Research
    RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.
    RDNT competitors
    NeoGenomics Inc (NEO)Diagnostics & Research
    NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia.
    NEO competitors
    Personalis Inc (PSNL)Diagnostics & Research
    Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
    PSNL competitors
    Legend Biotech Corp (LEGN)Biotechnology
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Qiagen NV (QGEN)Diagnostics & Research
    QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally.
    QGEN competitors
    Charles River Laboratories (CRL)Diagnostics & Research
    Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory...
    CRL competitors
    Castle Biosciences Inc (CSTL)Diagnostics & Research
    Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests...
    CSTL competitors
    Revvity Inc. (RVTY)Diagnostics & Research
    Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally.
    RVTY competitors

    Frequently Asked Questions About ADPT

    Who are Adaptive Biotechnologies' main competitors?

    The companies most similar to Adaptive Biotechnologies include CareDx (CDNA), GRAIL, LLC (GRAL), Sotera Health (SHC), Veracyte (VCYT) and RadNet (RDNT), listed from the closest match.

    Who is Adaptive Biotechnologies' biggest competitor?

    Revvity (RVTY) is the largest of the similar companies at $17.24B; CareDx (CDNA) is the closest match by business profile, size, sector and industry.

    How does ADPT stock compare with its competitors?

    ADPT's P/S is 15.0x against a peer median of 3.9x; its net margin is -23.7% against a peer median of 0.5%.

    Which of Adaptive Biotechnologies' competitors pays a higher dividend?

    Adaptive Biotechnologies pays no dividend. Qiagen NV (QGEN) and Revvity (RVTY) have higher forward dividend yields; Qiagen NV (QGEN) has the highest at 0.70%.

    Is Adaptive Biotechnologies bigger than its competitors?

    No. Adaptive Biotechnologies is 7th by market cap among the 13 companies on this page; the largest is Revvity (RVTY) at $17.24B.